

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 4.69684692 |
| 2 | DNA deamination (GO:0045006) | 4.60652150 |
| 3 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.53661464 |
| 4 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.40853712 |
| 5 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.34338919 |
| 6 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.27596047 |
| 7 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.27596047 |
| 8 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.27596047 |
| 9 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.23992288 |
| 10 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.23992288 |
| 11 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.21903580 |
| 12 | ribosome assembly (GO:0042255) | 4.19045258 |
| 13 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.12026422 |
| 14 | negative regulation of ligase activity (GO:0051352) | 4.12026422 |
| 15 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.11702579 |
| 16 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.11702579 |
| 17 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.03405744 |
| 18 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.01435376 |
| 19 | rRNA modification (GO:0000154) | 4.01299689 |
| 20 | protein deneddylation (GO:0000338) | 3.91677482 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.86383000 |
| 22 | cullin deneddylation (GO:0010388) | 3.83310707 |
| 23 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.81931837 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.58063376 |
| 25 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.52897116 |
| 26 | establishment of integrated proviral latency (GO:0075713) | 3.45803550 |
| 27 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.45224365 |
| 28 | establishment of viral latency (GO:0019043) | 3.44388544 |
| 29 | positive regulation of ligase activity (GO:0051351) | 3.41777123 |
| 30 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.40245538 |
| 31 | AMP metabolic process (GO:0046033) | 3.39707819 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 3.37971693 |
| 33 | positive regulation of cell cycle arrest (GO:0071158) | 3.35513706 |
| 34 | rRNA methylation (GO:0031167) | 3.35112554 |
| 35 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.34862316 |
| 36 | response to interferon-beta (GO:0035456) | 3.34266700 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 3.32140255 |
| 38 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.32140255 |
| 39 | pseudouridine synthesis (GO:0001522) | 3.26363148 |
| 40 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.25795812 |
| 41 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.13908359 |
| 42 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.13081928 |
| 43 | maturation of 5.8S rRNA (GO:0000460) | 3.12131467 |
| 44 | positive regulation of defense response to virus by host (GO:0002230) | 3.11882475 |
| 45 | regulation of cellular amine metabolic process (GO:0033238) | 3.09384089 |
| 46 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.07876211 |
| 47 | termination of RNA polymerase III transcription (GO:0006386) | 3.07274990 |
| 48 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.07274990 |
| 49 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.04408692 |
| 50 | adenosine metabolic process (GO:0046085) | 3.03034253 |
| 51 | response to gravity (GO:0009629) | 3.02946151 |
| 52 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.99724656 |
| 53 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.99724656 |
| 54 | tolerance induction (GO:0002507) | 2.96902686 |
| 55 | negative regulation of protein ubiquitination (GO:0031397) | 2.96795777 |
| 56 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.94736498 |
| 57 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.92261996 |
| 58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91530354 |
| 59 | protein complex biogenesis (GO:0070271) | 2.89880923 |
| 60 | regulation of ligase activity (GO:0051340) | 2.87997093 |
| 61 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.83763429 |
| 62 | regulation of cell cycle arrest (GO:0071156) | 2.82476003 |
| 63 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.82215286 |
| 64 | signal transduction in response to DNA damage (GO:0042770) | 2.81117352 |
| 65 | GTP biosynthetic process (GO:0006183) | 2.80917729 |
| 66 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.79116689 |
| 67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.79116689 |
| 68 | NADH dehydrogenase complex assembly (GO:0010257) | 2.79116689 |
| 69 | spliceosomal snRNP assembly (GO:0000387) | 2.78124948 |
| 70 | cytidine deamination (GO:0009972) | 2.77955347 |
| 71 | cytidine metabolic process (GO:0046087) | 2.77955347 |
| 72 | cytidine catabolic process (GO:0006216) | 2.77955347 |
| 73 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.77089308 |
| 74 | protein maturation by protein folding (GO:0022417) | 2.74341921 |
| 75 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.72048268 |
| 76 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.72048268 |
| 77 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.70786274 |
| 78 | regulation of defense response to virus by host (GO:0050691) | 2.68140549 |
| 79 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.67364494 |
| 80 | sleep (GO:0030431) | 2.67160745 |
| 81 | protein neddylation (GO:0045116) | 2.66989553 |
| 82 | rRNA processing (GO:0006364) | 2.66942215 |
| 83 | organelle disassembly (GO:1903008) | 2.66518142 |
| 84 | regulation of thymocyte apoptotic process (GO:0070243) | 2.66305213 |
| 85 | ribosomal large subunit biogenesis (GO:0042273) | 2.64130489 |
| 86 | rRNA metabolic process (GO:0016072) | 2.59933858 |
| 87 | tRNA metabolic process (GO:0006399) | 2.59065508 |
| 88 | cellular response to interleukin-15 (GO:0071350) | 2.58556289 |
| 89 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.58294526 |
| 90 | tRNA aminoacylation for protein translation (GO:0006418) | 2.57746800 |
| 91 | tRNA modification (GO:0006400) | 2.57740235 |
| 92 | amino acid activation (GO:0043038) | 2.56790120 |
| 93 | tRNA aminoacylation (GO:0043039) | 2.56790120 |
| 94 | cellular response to interferon-beta (GO:0035458) | 2.56474382 |
| 95 | tRNA processing (GO:0008033) | 2.55255461 |
| 96 | protein-cofactor linkage (GO:0018065) | 2.53277480 |
| 97 | mitochondrial RNA metabolic process (GO:0000959) | 2.52447476 |
| 98 | ribosome biogenesis (GO:0042254) | 2.51057577 |
| 99 | mannosylation (GO:0097502) | 2.50857889 |
| 100 | regulation of translational termination (GO:0006449) | 2.50456380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.69013906 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.42416564 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.71340847 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.68547769 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.33979054 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.12067731 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.01398706 |
| 8 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.99909795 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.94318531 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.73645793 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.68002770 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.65576707 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.60279655 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.59457985 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.59391775 |
| 16 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.46945448 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45013036 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.43287212 |
| 19 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.43281415 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.37798102 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.26747968 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.23336833 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.22394938 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21171321 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.19567534 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15960660 |
| 27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.14659495 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.99666487 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99041617 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98159728 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.96801483 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91365333 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.89643496 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.88608003 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87183651 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84997063 |
| 37 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.84843393 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77353618 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.77326822 |
| 40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.76607387 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75686406 |
| 42 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.71541753 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.71514862 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69715196 |
| 45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68899650 |
| 46 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.68280716 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66805068 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61595270 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60030506 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.58160025 |
| 51 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.57853124 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.57571849 |
| 53 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56783870 |
| 54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.55085971 |
| 55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.54680097 |
| 56 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.54037152 |
| 57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53184351 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.46336614 |
| 59 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.41557120 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40094221 |
| 61 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38903821 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.36108102 |
| 63 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.31358809 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.28516787 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26968658 |
| 66 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23920958 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23312969 |
| 68 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21196409 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19308010 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18883787 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.16616063 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15680229 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14698278 |
| 74 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14051932 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13850016 |
| 76 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.12275988 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09523165 |
| 78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08038823 |
| 79 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05994988 |
| 80 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02996835 |
| 81 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00415857 |
| 82 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.99460275 |
| 83 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99439711 |
| 84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99341949 |
| 85 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98301470 |
| 86 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98220038 |
| 87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94040800 |
| 88 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92506972 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 0.89314790 |
| 90 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85480660 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84992555 |
| 92 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84118419 |
| 93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82943343 |
| 94 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82697257 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82150889 |
| 96 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.81945162 |
| 97 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.80899894 |
| 98 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.80141366 |
| 99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.79251326 |
| 100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78677532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 3.54037654 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.45127452 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.19895850 |
| 4 | MP0005671_abnormal_response_to | 3.09638421 |
| 5 | MP0003436_decreased_susceptibility_to | 2.74883567 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.66018443 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 2.64863623 |
| 8 | MP0002006_tumorigenesis | 2.61500620 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.59176664 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.47262436 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.41697652 |
| 12 | MP0009785_altered_susceptibility_to | 2.37071621 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.29506489 |
| 14 | MP0003786_premature_aging | 2.25506442 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.25013693 |
| 16 | MP0005387_immune_system_phenotype | 2.24127387 |
| 17 | MP0001790_abnormal_immune_system | 2.24127387 |
| 18 | MP0001800_abnormal_humoral_immune | 2.13861297 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.13056679 |
| 20 | MP0001873_stomach_inflammation | 2.12185412 |
| 21 | MP0008058_abnormal_DNA_repair | 2.05143043 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.04519129 |
| 23 | MP0010094_abnormal_chromosome_stability | 1.96590021 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.95859260 |
| 25 | MP0004147_increased_porphyrin_level | 1.86083249 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.82317729 |
| 27 | MP0002723_abnormal_immune_serum | 1.81110639 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.80883375 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 1.77938578 |
| 30 | MP0003718_maternal_effect | 1.67842884 |
| 31 | MP0001819_abnormal_immune_cell | 1.65175992 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.64213805 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.63616404 |
| 34 | MP0009697_abnormal_copulation | 1.56816588 |
| 35 | MP0009764_decreased_sensitivity_to | 1.56647640 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 1.54893619 |
| 37 | MP0005165_increased_susceptibility_to | 1.53767557 |
| 38 | MP0001853_heart_inflammation | 1.50611948 |
| 39 | MP0008872_abnormal_physiological_respon | 1.47734460 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.40845667 |
| 41 | MP0003186_abnormal_redox_activity | 1.38445990 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.37280497 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.36613599 |
| 44 | MP0002398_abnormal_bone_marrow | 1.34283601 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.31113455 |
| 46 | MP0005360_urolithiasis | 1.30428559 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.29466582 |
| 48 | MP0001542_abnormal_bone_strength | 1.28072679 |
| 49 | MP0005025_abnormal_response_to | 1.28030066 |
| 50 | MP0001243_abnormal_dermal_layer | 1.27676489 |
| 51 | MP0002722_abnormal_immune_system | 1.27600810 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.27160344 |
| 53 | MP0000716_abnormal_immune_system | 1.27093464 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.23023039 |
| 55 | MP0001881_abnormal_mammary_gland | 1.19899669 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 1.18124006 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.18020743 |
| 58 | MP0002429_abnormal_blood_cell | 1.17655541 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.16896854 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.16585926 |
| 61 | MP0003077_abnormal_cell_cycle | 1.15248088 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.11779281 |
| 63 | MP0002419_abnormal_innate_immunity | 1.11406565 |
| 64 | MP0003195_calcinosis | 1.11150837 |
| 65 | MP0008469_abnormal_protein_level | 1.06806404 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 1.05853895 |
| 67 | MP0002405_respiratory_system_inflammati | 1.02945515 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.02715711 |
| 69 | MP0004947_skin_inflammation | 1.01034725 |
| 70 | MP0002163_abnormal_gland_morphology | 0.94546581 |
| 71 | MP0000358_abnormal_cell_content/ | 0.92782158 |
| 72 | MP0000490_abnormal_crypts_of | 0.92503539 |
| 73 | MP0003866_abnormal_defecation | 0.91432184 |
| 74 | MP0006054_spinal_hemorrhage | 0.88558846 |
| 75 | MP0002933_joint_inflammation | 0.87890943 |
| 76 | MP0000372_irregular_coat_pigmentation | 0.84840202 |
| 77 | MP0000749_muscle_degeneration | 0.84665545 |
| 78 | MP0002282_abnormal_trachea_morphology | 0.83272783 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.78441151 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 0.78083851 |
| 81 | MP0001727_abnormal_embryo_implantation | 0.77315885 |
| 82 | MP0008932_abnormal_embryonic_tissue | 0.76392273 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 0.75264223 |
| 84 | MP0002102_abnormal_ear_morphology | 0.74389155 |
| 85 | MP0000647_abnormal_sebaceous_gland | 0.72938321 |
| 86 | MP0003315_abnormal_perineum_morphology | 0.71548408 |
| 87 | MP0004084_abnormal_cardiac_muscle | 0.71286733 |
| 88 | MP0008873_increased_physiological_sensi | 0.70484954 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.69897288 |
| 90 | MP0008877_abnormal_DNA_methylation | 0.69250943 |
| 91 | MP0000627_abnormal_mammary_gland | 0.68663731 |
| 92 | MP0003045_fibrosis | 0.68381970 |
| 93 | MP0000858_altered_metastatic_potential | 0.68270253 |
| 94 | MP0001919_abnormal_reproductive_system | 0.67568102 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.66286502 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.64856788 |
| 97 | MP0005166_decreased_susceptibility_to | 0.63782362 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.63747557 |
| 99 | MP0002060_abnormal_skin_morphology | 0.63539972 |
| 100 | MP0001501_abnormal_sleep_pattern | 0.62132052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 4.32462635 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.92622211 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.85567981 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.80465572 |
| 5 | Increased CSF lactate (HP:0002490) | 3.77474852 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.65497398 |
| 7 | Increased serum pyruvate (HP:0003542) | 3.62868568 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.62602837 |
| 9 | Abnormality of glycolysis (HP:0004366) | 3.62415102 |
| 10 | Acute encephalopathy (HP:0006846) | 3.46334722 |
| 11 | Hepatic necrosis (HP:0002605) | 3.38369595 |
| 12 | Increased serum lactate (HP:0002151) | 3.33013906 |
| 13 | Abnormality of T cell physiology (HP:0011840) | 3.29156333 |
| 14 | Stomatitis (HP:0010280) | 3.28083953 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.20768971 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.13689161 |
| 17 | IgM deficiency (HP:0002850) | 3.13523392 |
| 18 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.06132692 |
| 19 | Hypoplasia of the uterus (HP:0000013) | 2.97820153 |
| 20 | Lipid accumulation in hepatocytes (HP:0006561) | 2.96117228 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 2.94459022 |
| 22 | Delayed CNS myelination (HP:0002188) | 2.92967203 |
| 23 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.77972324 |
| 24 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.77972324 |
| 25 | Abnormal protein glycosylation (HP:0012346) | 2.77972324 |
| 26 | Abnormal glycosylation (HP:0012345) | 2.77972324 |
| 27 | Cerebral edema (HP:0002181) | 2.73692954 |
| 28 | Exercise intolerance (HP:0003546) | 2.71423840 |
| 29 | Congenital, generalized hypertrichosis (HP:0004540) | 2.71034729 |
| 30 | Lactic acidosis (HP:0003128) | 2.66601102 |
| 31 | Hypoproteinemia (HP:0003075) | 2.62163918 |
| 32 | IgA deficiency (HP:0002720) | 2.59465471 |
| 33 | Renal cortical cysts (HP:0000803) | 2.57809444 |
| 34 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.54237353 |
| 35 | Abnormality of alanine metabolism (HP:0010916) | 2.54237353 |
| 36 | Hyperalaninemia (HP:0003348) | 2.54237353 |
| 37 | Abnormality of T cells (HP:0002843) | 2.51895043 |
| 38 | Rough bone trabeculation (HP:0100670) | 2.50992833 |
| 39 | Abnormality of the anterior horn cell (HP:0006802) | 2.49379570 |
| 40 | Degeneration of anterior horn cells (HP:0002398) | 2.49379570 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.44134099 |
| 42 | Entropion (HP:0000621) | 2.40989707 |
| 43 | Prostate neoplasm (HP:0100787) | 2.38547569 |
| 44 | Increased IgM level (HP:0003496) | 2.37716502 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36283990 |
| 46 | Tongue fasciculations (HP:0001308) | 2.34636257 |
| 47 | Renal Fanconi syndrome (HP:0001994) | 2.31325538 |
| 48 | Glucose intolerance (HP:0000833) | 2.31088732 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.29660293 |
| 50 | Pancytopenia (HP:0001876) | 2.27204327 |
| 51 | Opisthotonus (HP:0002179) | 2.25341051 |
| 52 | Testicular atrophy (HP:0000029) | 2.23751559 |
| 53 | Respiratory failure (HP:0002878) | 2.23195075 |
| 54 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.22932260 |
| 55 | Type 2 muscle fiber atrophy (HP:0003554) | 2.22449019 |
| 56 | Abnormality of the renal cortex (HP:0011035) | 2.22108455 |
| 57 | Abnormality of B cell number (HP:0010975) | 2.21839968 |
| 58 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.21787650 |
| 59 | Cholecystitis (HP:0001082) | 2.21315672 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.21315672 |
| 61 | Abnormality of the pons (HP:0007361) | 2.21010067 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.20899421 |
| 63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.18808715 |
| 64 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.18808715 |
| 65 | Exertional dyspnea (HP:0002875) | 2.16463158 |
| 66 | Chronic diarrhea (HP:0002028) | 2.15952446 |
| 67 | Conical tooth (HP:0000698) | 2.14177519 |
| 68 | Autoimmune hemolytic anemia (HP:0001890) | 2.14114778 |
| 69 | Abnormal spermatogenesis (HP:0008669) | 2.13953651 |
| 70 | Optic disc pallor (HP:0000543) | 2.12032799 |
| 71 | Severe combined immunodeficiency (HP:0004430) | 2.10131913 |
| 72 | Methylmalonic aciduria (HP:0012120) | 2.09539023 |
| 73 | Palpitations (HP:0001962) | 2.06991596 |
| 74 | Sparse eyelashes (HP:0000653) | 2.06020766 |
| 75 | Lethargy (HP:0001254) | 2.03826597 |
| 76 | Rhabdomyolysis (HP:0003201) | 2.03699202 |
| 77 | Stomach cancer (HP:0012126) | 2.02021419 |
| 78 | Myoglobinuria (HP:0002913) | 2.01301324 |
| 79 | Pustule (HP:0200039) | 2.00813116 |
| 80 | Muscle fiber atrophy (HP:0100295) | 1.99364211 |
| 81 | Pulmonary infiltrates (HP:0002113) | 1.96150313 |
| 82 | B lymphocytopenia (HP:0010976) | 1.94041760 |
| 83 | Ureteral duplication (HP:0000073) | 1.93143346 |
| 84 | Eosinophilia (HP:0001880) | 1.92018865 |
| 85 | Increased muscle lipid content (HP:0009058) | 1.91484431 |
| 86 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.90737150 |
| 87 | Muscle fibrillation (HP:0010546) | 1.89323516 |
| 88 | Neutropenia (HP:0001875) | 1.87722496 |
| 89 | Methylmalonic acidemia (HP:0002912) | 1.87373365 |
| 90 | Duplicated collecting system (HP:0000081) | 1.84137095 |
| 91 | Hypoplasia of the pons (HP:0012110) | 1.80412512 |
| 92 | Microvesicular hepatic steatosis (HP:0001414) | 1.79855871 |
| 93 | Granulocytopenia (HP:0001913) | 1.79577967 |
| 94 | Constricted visual fields (HP:0001133) | 1.76508206 |
| 95 | Abnormality of methionine metabolism (HP:0010901) | 1.75194083 |
| 96 | Abnormal trabecular bone morphology (HP:0100671) | 1.73329561 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 1.72530162 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72530162 |
| 99 | Generalized aminoaciduria (HP:0002909) | 1.71001045 |
| 100 | Myositis (HP:0100614) | 1.67161719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.01028511 |
| 2 | BUB1 | 3.33244982 |
| 3 | ZAK | 3.12316936 |
| 4 | VRK1 | 3.01015855 |
| 5 | TLK1 | 3.00660060 |
| 6 | TESK2 | 2.65122748 |
| 7 | EIF2AK3 | 2.52073211 |
| 8 | TSSK6 | 2.47048783 |
| 9 | TXK | 2.30655172 |
| 10 | MST4 | 2.22393808 |
| 11 | NUAK1 | 2.16390180 |
| 12 | EIF2AK1 | 2.10325458 |
| 13 | TAOK3 | 2.02033954 |
| 14 | NEK1 | 1.87656419 |
| 15 | MAP4K2 | 1.79109392 |
| 16 | SRPK1 | 1.76681512 |
| 17 | DAPK1 | 1.76434913 |
| 18 | TAF1 | 1.76434856 |
| 19 | BCKDK | 1.73897149 |
| 20 | TESK1 | 1.72817579 |
| 21 | PBK | 1.66975399 |
| 22 | EIF2AK2 | 1.62913498 |
| 23 | NME2 | 1.59494938 |
| 24 | MAP3K14 | 1.59395195 |
| 25 | CDK8 | 1.55722793 |
| 26 | PLK3 | 1.47082986 |
| 27 | MAPKAPK3 | 1.45924016 |
| 28 | SCYL2 | 1.40521031 |
| 29 | STK16 | 1.38267611 |
| 30 | WNK4 | 1.37819671 |
| 31 | LIMK1 | 1.28326690 |
| 32 | IKBKB | 1.27052548 |
| 33 | EPHA2 | 1.15041956 |
| 34 | KDR | 1.13761643 |
| 35 | NME1 | 1.12859818 |
| 36 | TRIM28 | 1.12748320 |
| 37 | BMPR1B | 1.08417694 |
| 38 | TBK1 | 1.04407642 |
| 39 | MAP3K12 | 1.03148949 |
| 40 | STK10 | 1.02293409 |
| 41 | ADRBK2 | 0.99598525 |
| 42 | TEC | 0.99064886 |
| 43 | MAPKAPK5 | 0.98421703 |
| 44 | CCNB1 | 0.97955907 |
| 45 | PHKG1 | 0.95994137 |
| 46 | PHKG2 | 0.95994137 |
| 47 | MAP2K2 | 0.95524424 |
| 48 | CAMKK2 | 0.93807355 |
| 49 | KIT | 0.87472718 |
| 50 | MYLK | 0.86046471 |
| 51 | IKBKE | 0.85799583 |
| 52 | MAP4K1 | 0.85407315 |
| 53 | PIM2 | 0.84174029 |
| 54 | ITK | 0.84001636 |
| 55 | RPS6KA5 | 0.83182950 |
| 56 | FLT3 | 0.83076159 |
| 57 | DAPK3 | 0.79216505 |
| 58 | ARAF | 0.76891678 |
| 59 | PAK4 | 0.76519603 |
| 60 | MUSK | 0.74520906 |
| 61 | CSNK1G3 | 0.73806858 |
| 62 | MOS | 0.72892702 |
| 63 | PLK2 | 0.72592571 |
| 64 | GRK6 | 0.71962868 |
| 65 | STK39 | 0.71536213 |
| 66 | AURKA | 0.68726195 |
| 67 | PDK2 | 0.67399304 |
| 68 | GRK1 | 0.66592980 |
| 69 | CSNK1A1L | 0.66088464 |
| 70 | IRAK3 | 0.65059323 |
| 71 | AURKB | 0.64894763 |
| 72 | TGFBR1 | 0.64503025 |
| 73 | PRKCI | 0.63689061 |
| 74 | MAP2K6 | 0.61862710 |
| 75 | PLK4 | 0.61328248 |
| 76 | LMTK2 | 0.61117786 |
| 77 | GRK5 | 0.60684789 |
| 78 | ILK | 0.55722362 |
| 79 | SMG1 | 0.52905044 |
| 80 | SYK | 0.52344606 |
| 81 | OXSR1 | 0.51904092 |
| 82 | CSNK1G1 | 0.50782839 |
| 83 | CDK7 | 0.48936368 |
| 84 | PIK3CG | 0.47645332 |
| 85 | STK4 | 0.44727021 |
| 86 | MKNK1 | 0.42829702 |
| 87 | CSNK1G2 | 0.42747535 |
| 88 | TTK | 0.41930780 |
| 89 | PTK2B | 0.41163109 |
| 90 | CHUK | 0.40225505 |
| 91 | BRSK2 | 0.40080633 |
| 92 | PLK1 | 0.39845449 |
| 93 | SIK3 | 0.39806196 |
| 94 | JAK3 | 0.38839111 |
| 95 | CDK9 | 0.38501809 |
| 96 | CSF1R | 0.37033547 |
| 97 | CDC7 | 0.35789272 |
| 98 | ADRBK1 | 0.35405633 |
| 99 | ERBB4 | 0.33419825 |
| 100 | GRK7 | 0.32448163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.74898790 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.89599322 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.57445640 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.47602330 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.46716226 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.31222780 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.24142168 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.21518314 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.20667582 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14349211 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.07866831 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.02147860 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.99193333 |
| 14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.91596828 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.90454473 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 1.89467030 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.87882396 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83582231 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75537809 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74435524 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73217539 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.70742296 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70549758 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.64013375 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.63454667 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55174736 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.53802980 |
| 28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.50855489 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.49652841 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.41470826 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.34323581 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33003065 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30331138 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27511894 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.24496802 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21369635 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19360319 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17169638 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15822620 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11199054 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10924907 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10656634 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00560079 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00282829 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98286544 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95592898 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94604035 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92963953 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92098434 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90390540 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89494189 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88948509 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88941183 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88745268 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88706496 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88182519 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87262298 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86591978 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77304370 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75152390 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74403246 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73084904 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.70507158 |
| 64 | Alcoholism_Homo sapiens_hsa05034 | 0.67246122 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65117118 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64499948 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63531407 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63286686 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63091045 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62949061 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62325482 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.61758477 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60389517 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.59093061 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.56447686 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54630551 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53824593 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53026642 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.51013894 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50948444 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44462007 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43593422 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43494628 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40598887 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38690674 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37566967 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36494012 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.35832204 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35330686 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34075063 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30267799 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29062942 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28725272 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27668757 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.27554261 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26971341 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26261193 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26109153 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26052009 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25840772 |

